By Conjoint Professor Dedee Frances Murrell

Journal articles

Rashid H; Lamberts A; Borradori L; Alberti-Violetti S; Barry RJ; Caproni M; Carey B; Carrozzo M; Caux F; Cianchini G; Corrà A; Diercks GFH; Dikkers FG; Di Zenzo G; Feliciani C; Geerling G; Genovese G; Hertl M; Joly P; Marzano AV; Meijer JM; Mercadante V; Murrell DF; Ormond M; Pas HH; Patsatsi A; Prost C; Rauz S; van Rhijn BD; Roth M; Schmidt E; Setterfield J; Zambruno G; Zillikens D; Horváth B, 2021, 'European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1750 - 1764, http://dx.doi.org/10.1111/jdv.17397

Clarke RA; Fang Z; Murrell D; Sherriff T; Eapen V, 2021, 'Gdf6 knockdown in a family with multiple synostosis syndrome and speech impairment', Genes, 12, http://dx.doi.org/10.3390/genes12091354

Fulchand S; Harris N; Li S; Barriga M; Gorell E; De Souza M; Murrell D; Marinkovich MP; Krishna Yenamandra V; Tang JY, 2021, 'Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey', Pediatric Dermatology, 38, pp. 1198 - 1201, http://dx.doi.org/10.1111/pde.14802

Su JC; Murashkin N; Wollenberg A; Svensson Å; Chernyshov P; Lio P; Murrell D; Nosbaum A; Faure S; Mery S; Stalder JF, 2021, 'Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study', Jaad International, 4, pp. 13 - 14, http://dx.doi.org/10.1016/j.jdin.2021.04.005

Lin G; Murase JE; Murrell DF; Godoy LDC; Grant-Kels JM, 2021, 'The impact of gender in mentor–mentee success: Results from the Women's Dermatologic Society Mentorship Survey', International Journal of Women S Dermatology, 7, pp. 398 - 402, http://dx.doi.org/10.1016/j.ijwd.2021.04.010

Patsatsi A; Murrell DF, 2021, 'Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.708071

Ho G; Blake SC; Sheriff T; Daniel BS; Murrell DF, 2021, 'Impact of COVID-19 on inpatient dermatology consults in an Australian tertiary hospital', Australasian Journal of Dermatology, 62, pp. 427 - 428, http://dx.doi.org/10.1111/ajd.13649

Ho G; Sheriff T; Doria-Ruiz M; Loh Y; Murrell DF, 2021, 'Are biosimilars for pemphigus safe?', Clinical and Experimental Dermatology, 46, pp. 942 - 943, http://dx.doi.org/10.1111/ced.14610

Murrell DF; Joly P; Werth VP, 2021, 'Individual patients’ risk factors impact guidelines for prophylactic agents used in pemphigus patients treated with rituximab', Journal of the American Academy of Dermatology, 85, pp. e47 - e48, http://dx.doi.org/10.1016/j.jaad.2021.03.018

Silverberg JI; Pinter A; Alavi A; Lynde C; Bouaziz JD; Wollenberg A; Murrell DF; Alpizar S; Laquer V; Chaouche K; Ahmad F; Armstrong JM; Piketty C, 2021, 'Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1562 - 1568, http://dx.doi.org/10.1111/jdv.17218

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 85, pp. 1 - 14, http://dx.doi.org/10.1016/j.jaad.2020.11.076

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Subepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 85, pp. 18 - 27, http://dx.doi.org/10.1016/j.jaad.2020.05.161

Kasperkiewicz M; Schmidt E; Amagai M; Fairley JA; Joly P; Murrell DF; Payne AS; Yale ML; Zillikens D; Woodley DT, 2021, 'Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic', Journal of the European Academy of Dermatology and Venereology, 35, pp. e412 - e414, http://dx.doi.org/10.1111/jdv.17207

Murrell DF; Paul CF, 2021, 'What instruments should we add to our toolbox for measuring the severity and control of eczema?', British Journal of Dermatology, 185, pp. 13 - 14, http://dx.doi.org/10.1111/bjd.20398

Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS, 2021, 'Intraepithelial autoimmune blistering dermatoses: Clinical features and diagnosis', Journal of the American Academy of Dermatology, 84, pp. 1507 - 1519, http://dx.doi.org/10.1016/j.jaad.2020.11.075

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy', Journal of the American Academy of Dermatology, 84, pp. 1523 - 1537, http://dx.doi.org/10.1016/j.jaad.2021.02.073

Murrell DF; Murase JE, 2021, 'The International Reach of the International Journal of Women's Dermatology and the Women's Dermatologic Society', International Journal of Women S Dermatology, 7, pp. 235 - 236, http://dx.doi.org/10.1016/j.ijwd.2021.05.004

Ramirez-Quizon M; Murrell DF, 2021, 'Managing epidermolysis bullosa during the coronavirus pandemic: Experience and ideals', Clinics in Dermatology, 39, pp. 369 - 373, http://dx.doi.org/10.1016/j.clindermatol.2021.01.014

Lincoln V; Chao L; Woodley DT; Murrell D; Kim M; O'Toole EA; Ly A; Cogan J; Mosallaei D; Wysong A; Chen M, 2021, 'Over-expression of stromal periostin correlates with poor prognosis of cutaneous squamous cell carcinomas', Experimental Dermatology, 30, pp. 698 - 704, http://dx.doi.org/10.1111/exd.14281

Viti G; Forcella C; Feliciani C; Murrell DF, 2021, 'Beyond the skin: Disease parameters in pemphigus', Italian Journal of Dermatology and Venereology, 156, pp. 147 - 150, http://dx.doi.org/10.23736/S2784-8671.21.06678-5

Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF, 2021, 'A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Jaad International, 2, pp. 134 - 152, http://dx.doi.org/10.1016/j.jdin.2020.12.007

Murase JE; Murrell DF, 2021, 'Heralding change within dermatology: Response of the International Journal of Women's Dermatology (IJWD) to the twin pandemic of racism', International Journal of Women S Dermatology, 7, pp. 125 - 126, http://dx.doi.org/10.1016/j.ijwd.2021.03.008

Krueger JG; Murrell DF; Garcet S; Navrazhina K; Lee PC; Muscianisi E; Blauvelt A, 2021, 'Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis', Journal of Allergy and Clinical Immunology, 147, pp. 1107 - 1109.e2, http://dx.doi.org/10.1016/j.jaci.2020.09.021

Daniel BS; Murrell DF, 2021, 'The role of women as past and present advocates for vaccinations: Relevance in the COVID-19 setting', International Journal of Women S Dermatology, 7, pp. 228 - 229, http://dx.doi.org/10.1016/j.ijwd.2020.10.001

Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS, 2021, 'Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”', Journal of the American Academy of Dermatology, 84, pp. e61 - e62, http://dx.doi.org/10.1016/j.jaad.2020.09.002

Barua DP; Chowdhury MIH; Mowla MR; Reich A; Murrell D; Ruzicka T, 2021, 'Comparison of effectiveness of topical tacrolimus 0.1% vs topical halobetasol propionate 0.05% as an add-on to oral hydroxychloroquine in discoid lupus erythematosus', Dermatologic Therapy, 34, http://dx.doi.org/10.1111/dth.14675

Sheriff T; Dickenson-Panas H; Murrell DF, 2021, 'Conducting dermatology clinical trials during the COVID-19 pandemic', Clinics in Dermatology, 39, pp. 104 - 106, http://dx.doi.org/10.1016/j.clindermatol.2020.12.019

Sabourirad S; Peera MR; Wilcsek G; Murrell DF, 2021, 'Ectropion surgery might not be a long-term solution for harlequin ichthyosis', Dermatologic Therapy, 34, http://dx.doi.org/10.1111/dth.14646

Rogers C; Gibson M; Kern JS; Martin LK; Robertson SJ; Su JC; Daniel BS; Murrell DF, 2021, '157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Journal of Investigative Dermatology, 141, pp. S28 - S28, http://dx.doi.org/10.1016/j.jid.2021.02.177

Wilson BN; Sun M; Olayinka J; Murrell DF; Murase J, 2021, '557 Assessment of skin of color and diversity and inclusion content published in the Journal of Investigative Dermatology: An analysis and call to action', Journal of Investigative Dermatology, 141, pp. S97 - S97, http://dx.doi.org/10.1016/j.jid.2021.02.584

Bruckner A; Kern JS; Sprecher E; Fernandez M; Cunningham T; Sumeray M; Murrell DF, 2021, '615 Efficacy and safety of Oleogel-S10 (birch triterpenes) for recessive dystrophic epidermolysis bullosa (RDEB): Results of 3 months double-blind treatment of the phase 3 study ‘EASE’', Journal of Investigative Dermatology, 141, pp. S107 - S107, http://dx.doi.org/10.1016/j.jid.2021.02.644

Sabourirad S; Murrell DF, 2021, 'A dark lesion on an Indian Woman's vulva', International Journal of Women's Dermatology, 7, pp. 201 - 202, http://dx.doi.org/10.1016/j.ijwd.2021.02.004

Murrell DF; Marinovic B; Caux F, 2021, 'Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts (vol 72, pg 168, 2015)', JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 85, pp. 533 - 534

Bodemer C; Kern J; Sprecher E; Bruckner AL; Davis C; Cunningham T; Sumeray M; Murrell DF, 2021, 'Efficacité et innocuité de l’Oleogel-S10 (triterpènes de bouleau) dans l’épidermolyse bulleuse : résultats à 3 mois de l’étude de phase 3 « EASE » en double aveugle', Annales de Dermatologie et de Vénéréologie - FMC, 1, pp. A107 - A107, http://dx.doi.org/10.1016/j.fander.2021.09.525

Montagnon CM; Lehman JS; Murrell DF; Camilleri MJ; Tolkachjov SN, 2021, 'Intraepithelial autoimmune bullous dermatoses disease activity assessment and therapy (vol 84, pg 1523, 2021)', JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 85, pp. 799 - 799

Mazure CM; Williams ML, 2021, 'Introduction and purpose: The House of Medicine & Dermatology.', Int J Womens Dermatol, 7, pp. 517 - 518, http://dx.doi.org/10.1016/j.ijwd.2021.09.005

Murrell DF; Cheesborough J; Woodley DT, 2021, 'Obituary: Vale Robert Alan Briggaman MD 1934-2020', BRITISH JOURNAL OF DERMATOLOGY, 184, pp. 379 - 380, http://dx.doi.org/10.1111/bjd.19404

Su JC; Murashkin N; Wollenberg A; Svensson A; Chernyshov P; Lio P; Murrell D; Nosbaum A; Faure S; Mery S; Stalder J-F, 2021, 'Pharmacist recommendations regarding topical steroiduse may contradict the standard of care in atopic dermatitis: An international, cross-sectional study (vol 4, pg 13, 2021)', JAAD INTERNATIONAL, 4, pp. 58 - 58

Kang M; Bilgic A; Radjenovic M; Murrell DF, 2020, 'Osteoporosis and bone health in autoimmune blistering skin disease—an evidenced based review', Journal of the European Academy of Dermatology and Venereology, 34, pp. 2745 - 2756, http://dx.doi.org/10.1111/jdv.16334

Goldman MP; Murrell DF; Al-Mutairi N; Arenbergerova M; Dréno B; Alhaddad M; Al-Suwaidan SN; Firooz A; van de Kerkhof PCM; Feldman SR, 2020, 'International collaboration', Journal of Dermatological Treatment, 31, pp. 757, http://dx.doi.org/10.1080/09546634.2020.1794290

Woodley DT; Murrell DF, 2020, 'A giant in dermatology has fallen: Robert Alan "Al'' Briggaman, MD IN MEMORY', JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 83, pp. E381 - E381, http://dx.doi.org/10.1016/j.jaad.2020.06.076

Schwartz RA; Pradhan S; Murrell DF; Jafferany M; Olisova OY; Lomonosov KM; Lotti T; Goldust M, 2020, 'COVID-19 and immunosuppressive therapy in dermatology', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.14140

Goldust M; Sharma A; Murrell DF; Kazemi N; Rudnicka L; Kassir M; Navarini A; Mueller SM, 2020, 'Dermatology and specialty rotations: COVID-19 may reemphasize the importance of internal medicine', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13996

Gorell ES; Wolstencroft PW; de Souza MP; Murrell DF; Linos E; Tang JY, 2020, 'Financial burden of epidermolysis bullosa on patients in the United States', Pediatric Dermatology, 37, pp. 1198 - 1201, http://dx.doi.org/10.1111/pde.14340

van Beek N; Krüger S; Fuhrmann T; Lemcke S; Goletz S; Probst C; Komorowski L; Di Zenzo G; Dmochowski M; Drenovska K; Horn M; Jedlickova H; Kowalewski C; Medenica L; Murrell D; Patsatsi A; Geller S; Uzun S; Vassileva S; Zhu X; Fechner K; Zillikens D; Stöcker W; Schmidt E; Rentzsch K, 2020, 'Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology', Journal of the American Academy of Dermatology, 83, pp. 1315 - 1322, http://dx.doi.org/10.1016/j.jaad.2020.01.049

Murrell DF; Kroumpouzos G; Gupta A; di Lernia V; Sadoughifar R; Goldust M, 2020, 'Role of music therapy in reducing the burden of dermatological diseases during COVID-19', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.14086

Ferries L; Gillibert A; Duvert-Lehembre S; Corbaux C; Alexandre M; Prost-Squarcioni C; Caux F; Delaporte E; Litrowski N; Boulard C; Murrell DF; Joly P; Hébert V, 2020, 'Sensitivity to change and correlation between the autoimmune bullous disease quality-of-life questionnaires ABQOL and TABQOL, and objective severity scores', British Journal of Dermatology, 183, pp. 944 - 945, http://dx.doi.org/10.1111/bjd.19173

Azimi SZ; Firooz A; Murrell DF; Daneshpazhooh M, 2020, 'Treatment concerns for bullous pemphigoid in the COVID-19 pandemic era', Dermatologic Therapy, 33, http://dx.doi.org/10.1111/dth.13956

Has C; Bauer JW; Bodemer C; Bolling MC; Bruckner-Tuderman L; Diem A; Fine JD; Heagerty A; Hovnanian A; Marinkovich MP; Martinez AE; McGrath JA; Moss C; Murrell DF; Palisson F; Schwieger-Briel A; Sprecher E; Tamai K; Uitto J; Woodley DT; Zambruno G; Mellerio JE, 2020, 'Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility', British Journal of Dermatology, 183, pp. 614 - 627, http://dx.doi.org/10.1111/bjd.18921

Murrell DF; Lucky AW; Salas-Alanis JC; Woodley DT; Palisson F; Natsuga K; Nikolic M; Ramirez-Quizon M; Paller AS; Lara-Corrales I; Barzegar MA; Sprecher E; Has C; Laimer M; Bruckner AL; Bilgic A; Nanda A; Purvis D; Hovnanian A; Murat-Sušić S; Bauer J; Kern JS; Bodemer C; Martin LK; Mellerio J; Kowaleski C; Robertson SJ; Bruckner-Tuderman L; Pope E; Marinkovich MP; Tang JY; Su J; Uitto J; Eichenfield LF; Teng J; Aan Koh MJ; Lee SE; Khuu P; Rishel HI; Sommerlund M; Wiss K; Hsu CK; Chiu TW; Martinez AE, 2020, 'Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts', Journal of the American Academy of Dermatology, 83, pp. 1222 - 1224, http://dx.doi.org/10.1016/j.jaad.2020.06.1023

Back to profile page